Full Text View
Tabular View
No Study Results Posted
Related Studies
A One Year Open Label Study for the Treatment of Hypogonadism (Low Testosterone) in Men Who Have Completed ZA-203
This study has been completed.
Study NCT01386567   Information provided by Repros Therapeutics Inc.

First Received on June 29, 2011.   Last Updated on May 16, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypogonadism
Low Testosterone
More general conditions related to this trial
Endocrine System Diseases
Gonadal Disorders
Interventions listed in this trial
Androxal (enclomiphene citrate)
Testim (topical testosterone)
Additional drug interventions recognized in this trial
Citric Acid
Clomiphene
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate
More general drug interventions related to this trial
Anabolic Agents
Androgens
Anticoagulants
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Chelating Agents
Estrogen Antagonists
Estrogen Receptor Modulators
Fertility Agents
Fertility Agents, Female
Hematologic Agents
Hormone Antagonists
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Selective Estrogen Receptor Modulators
Therapeutic Uses
Sponsors listed in this trial
Repros Therapeutics Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services